Metabolic Health
Cinnamomum species, including Cinnamomum verum and Cinnamomum cassia
Cinnamon is a widely used culinary botanical studied for blood-glucose control and selected weight-related outcomes. Human evidence suggests possible modest metabolic effects in some populations, but results are inconsistent and vary substantially by species, dose and preparation.
Culinary cinnamon, powdered cinnamon, capsules and standardized extracts are assessed separately where relevant. Species matters because cassia cinnamon generally contains more coumarin than Ceylon cinnamon.
Evidence assessment
Systematic reviews and meta-analyses suggest cinnamon supplementation may reduce fasting blood glucose in some people with type 2 diabetes and may produce small reductions in body weight or BMI in some studies. However, effects on HbA1c and other metabolic outcomes are inconsistent, and heterogeneity across trials is substantial. Current evidence supports a possible adjunctive role rather than a treatment-level claim.
Trials vary by cinnamon species, dose, preparation, duration, participant characteristics and background treatment. Some studies do not identify the cinnamon species used. Differences in coumarin content, extract standardisation and study quality make direct comparison difficult. Positive findings should not be interpreted as evidence that cinnamon is equivalent to licensed diabetes or weight-management treatment.
BodyRepair has low confidence in practical use because the evidence is limited, inconsistent, difficult to apply or affected by important safety or preparation concerns.
Safety assessment
Cinnamon used in ordinary culinary amounts is generally lower risk. Larger supplemental doses or prolonged use require greater caution, particularly with cassia cinnamon because it can contain substantial amounts of coumarin. High or prolonged coumarin exposure may be a concern for liver health in susceptible people.
Interaction review
Potential interactions should be reviewed in relation to the botanical preparation, dose, frequency, prescribed medicines, supplements and individual health circumstances.
Cinnamon may lower blood glucose in some people and could add to the effects of glucose-lowering treatment.
People taking diabetes medicines should discuss regular high-dose cinnamon supplementation with their clinician or pharmacist.
Because cassia cinnamon can contain coumarin, prolonged high intake may be a concern when combined with medicines that also affect liver function.
Seek pharmacist or prescriber advice before using high-dose cassia cinnamon supplements alongside medicines with liver-related cautions.
Potential interactions depend on cinnamon species, preparation, dose and concurrent treatment.
Check concentrated cinnamon supplement use with a pharmacist when taking regular prescription medicines.
Do not stop, replace or alter prescribed treatment because of botanical information without advice from an appropriately qualified healthcare professional.
Clinical suitability
Contraindications should be considered in relation to the botanical species, preparation, dose, diagnosed conditions, age, pregnancy, breastfeeding and planned procedures.
Cassia cinnamon can contain coumarin, which may worsen liver problems when exposure is high or prolonged.
Avoid high-dose cassia cinnamon supplements without medical advice.
Food-level cinnamon intake is different from high-dose supplementation. Safety of larger supplemental amounts during pregnancy is uncertain.
Use culinary amounts unless an appropriately qualified clinician advises otherwise.
There is limited information about the safety of high-dose cinnamon supplementation during breastfeeding.
Prefer culinary amounts and seek professional advice before using concentrated supplements.
Cinnamon may trigger allergic or irritant reactions in susceptible people.
Avoid cinnamon products that have previously caused an allergic reaction.
Where pregnancy, breastfeeding, surgery, a diagnosed condition, significant symptoms or prescribed treatment are relevant, professional review should take priority over self-directed use.
BodyRepair Interpretation
Cinnamon may have a modest supportive role within metabolic-health and nourishment strategies, particularly for fasting blood-glucose control in some populations, but the evidence is inconsistent and should not be overstated. BodyRepair does not consider cinnamon a treatment equivalent to licensed diabetes or weight-management medicines. Species identification is important because cassia and Ceylon cinnamon differ materially in coumarin exposure.
Living evidence record
New studies, safety information, corrections, editorial decisions and version changes remain visible here.
The record was strengthened with clearer evidence limitations, species-specific coumarin safety, interaction cautions and a more explicit separation between culinary use and concentrated supplementation.
An updated systematic review of randomized trials assessed cinnamon supplementation for glycaemic control in people with type 2 diabetes, adding to a mixed evidence base with variable results across fasting glucose and HbA1c outcomes.
A systematic review and meta-analysis of randomized trials reported small reductions in body weight and BMI with cinnamon supplementation, while identifying substantial heterogeneity across studies.
NCCIH notes that prolonged high intake of cassia cinnamon may be a concern for people with liver disease because coumarin exposure varies by species and product.
Evidence status may change as new research, safety information and human editorial review become available. BodyRepair records material changes rather than treating botanical evidence as permanently settled.
Human review history
Source register
Species differences, adverse effects, coumarin exposure, liver-safety context and general evidence limitations.
Open sourceGlycaemic evidence and diabetes-related supplement safety context.
Open sourceUpdated glycaemic-control systematic review and meta-analysis.
Open sourceWeight and body-composition systematic review and meta-analysis.
Open sourceFuture evidence monitoring
BodyRepair may use artificial intelligence to identify new research, safety notices, corrections and retractions relevant to this botanical.
AI-generated findings remain drafts until reviewed and approved through the BodyRepair editorial process.
BodyRepair Botanical Therapies
Return to Botanical Therapies or explore the wider Evidence Centre.
